Cardiometabolic Syndrome Clinical Trial
Official title:
Establishing Clinical Utility Evidence for Chronic Disease Management Testing (CDMT): A CPV® RandomizedControlled Trial
This is a national-level research study of primary care physicians. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.
The results of this study could contribute to improved quality of care for patients by encouraging better care practices and adherence to evidence-based guidance. The data from this study will be submitted to a national journal for publication. The study plans to enroll up to 300 physicians. Upon consenting and agreeing to participate in this study, participants will be asked to care for 3 simulated patient cases, known as Clinical Performance and Value Vignettes (CPV®). CPVs describe patients physicians typically encounter in their daily practice and are not meant to be difficult. In each vignette, physicians are asked to share their expected care through 5 domains: 1) history, 2) physical exam, 3) diagnostic workup, 4) diagnosis and 5) treatment and follow-up. Each case takes approximately 15-20 minutes to complete and we estimate the time commitment for each round of CPV administration to be approximately 45 - 60 minutes. All responses to the cases will be completed online and will be kept confidential. Over 2 CPV administration rounds, the total time to care for the simulated patients is estimated at 1.5-2 hours. If physicians are randomized to an intervention group in this study, they will receive education materials on a diagnostic test currently available for use in the market after the first round of CPV administration. They are asked to review these materials before moving to the next CPV administration round. Time to review education materials is estimated to be approximately 15 minutes. Depending on the results of this randomized controlled trial, there may be an opportunity for physicians to re-enroll into a follow-on study. If they choose to participate in this second study, they will be asked to identify and send de-identified records of patients in their practice that are similar to the simulated patients they previously cared for in this study. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05880758 -
Impact of Yo-Yo Sleep on Cardiometabolic Health
|
N/A | |
Completed |
NCT06058845 -
Efficacy of Tamarindus Indica Fruit Juice in Optimizing Cardiometabolic Health of Patients Living With HIV
|
N/A | |
Completed |
NCT05473026 -
Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors
|
N/A | |
Enrolling by invitation |
NCT06284772 -
FINRISK 2002 Re-examination
|
||
Completed |
NCT05071833 -
Effects of Peppermint Oil in Cardiometabolic Outcomes
|
N/A | |
Active, not recruiting |
NCT05309057 -
Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk
|
||
Recruiting |
NCT05897073 -
Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity
|
N/A | |
Recruiting |
NCT06371937 -
iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease
|
||
Recruiting |
NCT06003686 -
Spinal Cord Injury Model Systems (SCIMS) - Education Module
|
N/A | |
Recruiting |
NCT05775016 -
Effects of Adding L-BAIBA to Exercising Adult Overweight and Obese Men and Women
|
N/A | |
Recruiting |
NCT05350111 -
CArdioMetabolic Prevention in Adolescents
|
N/A | |
Completed |
NCT06158191 -
Long-term Benefits of Abdominal Fat Loss in Abdominally Obese Dyslipidemic Patients (SYNERGIE Study)
|
N/A | |
Recruiting |
NCT04801745 -
Vegan Diet, Amla Fruits and Uric Acid
|
N/A | |
Not yet recruiting |
NCT06230861 -
Effects of Quercetin on Cardiometabolic Outcomes
|
N/A | |
Active, not recruiting |
NCT05627570 -
A Study Comparing the Health Effects of Two Diets Following UK Dietary Guidance in People Living With Overweight or Obesity
|
N/A | |
Active, not recruiting |
NCT04784624 -
Virtual Lifestyle Program Evaluation During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
|
||
Enrolling by invitation |
NCT05079529 -
Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome
|
Phase 2 | |
Completed |
NCT04776629 -
A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors
|
Phase 2 | |
Completed |
NCT06457711 -
Blood Pressure and Cardiometabolic Risk (Diet-to-HTN)
|
N/A | |
Completed |
NCT06008886 -
Effect of a Vegan Diet Versus a Mediterranean Diet. Assessing Health Outcomes
|
N/A |